Insider acquisitions
Explore purchases, stock awards, gifts, exercises, and conversions. These records cover acquisitions only; sales are not included.
Transaction timeline & trade size
Choose a reporting owner, transaction period, and security. Open any point for the filing.
Purchases in this page5
Other acquisitions45
Reporting owners29
SalesNot providedCheck original SEC filings
Nov 21, 2025 – Nov 25, 2025 · Transaction dates · Current page sample
Reported quantity · security units
WILLAMETTE VALLEY VINEYARDS INC · Common Stock · Purchase (code P) · Non-derivative · Currency not specified
Swipe the chart to see the full date range. Exact records are available in the table below.
1 transactions plotted for one security and transaction type. 0 have no reported quantity. A value chart requires a stated currency. Individual reported values remain visible in the table.
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition
50 dated transactions in this page sample · 29 reporting owners.
View timeline as a table
| Transaction date | Company / security | Reporting owners | Acquisition type | Quantity | Price | Reference value | Currency |
|---|---|---|---|---|---|---|---|
| Nov 24, 2025 | WILLAMETTE VALLEY VINEYARDS INCCommon Stock | TUREL STANLEY G (Director) | Purchase | 1,900 | 2.59 | 4,921 | Currency not specified |
| Nov 25, 2025 | Allegion plcOrdinary Shares | PETERS LAUREN B (Director) | Purchase | 1,600 | 165.4409 | 264,705.44 | Currency not specified |
| Nov 21, 2025 | Tamboran Resources CorpCommon Stock | PACE PHILLIP Z (Director) | Purchase | 2,000 | 23.5 | 47,000 | Currency not specified |
| Nov 21, 2025 | NEKTAR THERAPEUTICSStock Option | Zalevsky Jonathan (Chief R&D Officer) | Stock award | 4,766 | 0 | 0 | Currency not specified |
| Nov 21, 2025 | NEKTAR THERAPEUTICSCommon Stock | Zalevsky Jonathan (Chief R&D Officer) | Stock award | 2,666 | 0 | 0 | Currency not specified |
| Nov 21, 2025 | NEKTAR THERAPEUTICSStock Option | Wilson Mark Andrew (Chief Legal Officer) | Stock award | 3,400 | 0 | 0 | Currency not specified |
| Nov 21, 2025 | NEKTAR THERAPEUTICSCommon Stock | Wilson Mark Andrew (Chief Legal Officer) | Stock award | 1,903 | 0 | 0 | Currency not specified |
| Nov 21, 2025 | NEKTAR THERAPEUTICSStock Option | ROBIN HOWARD W (President & CEO · Director) | Stock award | 12,170 | 0 | 0 | Currency not specified |
| Nov 21, 2025 | NEKTAR THERAPEUTICSCommon Stock | ROBIN HOWARD W (President & CEO · Director) | Stock award | 7,110 | 0 | 0 | Currency not specified |
| Nov 24, 2025 | Azenta, Inc.Common | Lin Lawrence Y. (EVP, CFO and Treasurer) | Stock award | 36,681 | 0 | 0 | Currency not specified |
| Nov 24, 2025 | Azenta, Inc.Common | Pirogova Olga (SVP and CHRO) | Stock award | 16,303 | 0 | 0 | Currency not specified |
| Nov 24, 2025 | Azenta, Inc.Common | Zhou Ginger (SVP and GM, Multiomics) | Stock award | 13,042 | 0 | 0 | Currency not specified |
| Nov 24, 2025 | Azenta, Inc.Common | Starr Ephraim (SVP, Gen Counsel & Secretary) | Stock award | 34,235 | 0 | 0 | Currency not specified |
| Nov 24, 2025 | NEWMARKET CORPCommon Stock | GOTTWALD THOMAS E (Chairman, President & CEO · Director) | Gift received | 51 | 0 | 0 | Currency not specified |
| Nov 24, 2025 | NEWMARKET CORPCommon Stock | GOTTWALD THOMAS E (Chairman, President & CEO · Director) | Gift received | 51 | 0 | 0 | Currency not specified |
| Nov 24, 2025 | NEWMARKET CORPCommon Stock | GOTTWALD THOMAS E (Chairman, President & CEO · Director) | Gift received | 51 | 0 | 0 | Currency not specified |
| Nov 24, 2025 | NEWMARKET CORPCommon Stock | GOTTWALD THOMAS E (Chairman, President & CEO · Director) | Gift received | 51 | 0 | 0 | Currency not specified |
| Nov 21, 2025 | Ceribell, Inc.Common Stock | Chao Xingjuan (President and CEO · Director) | Exercise / conversion | 25,000 | 3.65 | 91,250 | Currency not specified |
| Nov 21, 2025 | Ceribell, Inc.Common Stock | Chao Xingjuan (President and CEO · Director) | Exercise / conversion | 25,000 | 2.24 | 56,000 | Currency not specified |
| Nov 21, 2025 | Reservoir Media, Inc.Common stock, $0.0001 par value | Rothstein Adam (Director) | Stock award | 684 | 7.3 | 4,993.2 | Currency not specified |
| Nov 21, 2025 | Reservoir Media, Inc.Common stock, $0.0001 par value | Field Ezra S. (Director) | Stock award | 1,712 | 7.3 | 12,497.6 | Currency not specified |
| Nov 21, 2025 | Reservoir Media, Inc.Common stock, $0.0001 par value | Cook Stephen M. (Director) | Stock award | 684 | 7.3 | 4,993.2 | Currency not specified |
| Nov 21, 2025 | Reservoir Media, Inc.Common stock, $0.0001 par value | Taylor Ryan P. (Director) | Stock award | 684 | 7.3 | 4,993.2 | Currency not specified |
| Nov 24, 2025 | MAXIMUS, INC.Common Stock | Mutryn David (Chief Financial Officer) | Stock award | 10,259 | 0 | 0 | Currency not specified |
| Nov 24, 2025 | MAXIMUS, INC.Common Stock | Martinez John Thomas (Chief Legal Officer) | Stock award | 7,409 | 0 | 0 | Currency not specified |
| Nov 24, 2025 | MAXIMUS, INC.Common Stock | Baylinson Ilene R. (General Mgr - Health & Human) | Stock award | 7,409 | 0 | 0 | Currency not specified |
| Nov 24, 2025 | MAXIMUS, INC.Common Stock | Link Michelle F. (Chief of Human Resources) | Stock award | 6,013 | 0 | 0 | Currency not specified |
| Nov 24, 2025 | MAXIMUS, INC.Common Stock | GOLINVAUX THERESA D (Principal Accounting Officer) | Stock award | 2,565 | 0 | 0 | Currency not specified |
| Nov 22, 2025 | HARMONIC INC.Common Stock | Jankovic Walter (Chief Financial Officer) | Exercise / conversion | 6,645 | 0 | 0 | Currency not specified |
| Nov 21, 2025 | Strategy IncSeries A Perpetual Stretch Preferred Stock | Dietze Jane A (Director) | Purchase | 1,100 | 95.28 | 104,808 | Currency not specified |
| Nov 21, 2025 | ClearPoint Neuro, Inc.Common Stock | D'Alessandro Danilo (Chief Financial Officer) | Exercise / conversion | 3,555 | 8.1 | 28,795.5 | Currency not specified |
| Nov 21, 2025 | Enova International, Inc.Common stock, par value $0.00001 per share | Fisher David (Chief Executive Officer · Director) | Exercise / conversion | 6,000 | 23.96 | 143,760 | Currency not specified |
| Nov 24, 2025 | Millrose Properties, Inc.Class A Common Stock | Lynch Kathleen B. (Director) | Purchase | 1,860 | 31.738 | 59,032.68 | Currency not specified |
| Nov 21, 2025 | Xilio Therapeutics, Inc.Stock Option (right to buy) | Brennan Kevin M. (SVP, FINANCE AND ACCOUNTING) | Stock award | 20,000 | Not reported | Not reported | Currency not specified |
| Nov 21, 2025 | Xilio Therapeutics, Inc.Stock Option (right to buy) | Brennan Kevin M. (SVP, FINANCE AND ACCOUNTING) | Stock award | 25,000 | Not reported | Not reported | Currency not specified |
| Nov 21, 2025 | Xilio Therapeutics, Inc.Stock Option (right to buy) | Brennan Kevin M. (SVP, FINANCE AND ACCOUNTING) | Stock award | 55,000 | Not reported | Not reported | Currency not specified |
| Nov 21, 2025 | Xilio Therapeutics, Inc.Stock Option (right to buy) | Brennan Kevin M. (SVP, FINANCE AND ACCOUNTING) | Stock award | 131,700 | 0 | 0 | Currency not specified |
| Nov 21, 2025 | Xilio Therapeutics, Inc.Stock Option (right to buy) | Luptakova Katarina (CHIEF MEDICAL OFFICER) | Stock award | 106,000 | Not reported | Not reported | Currency not specified |
| Nov 21, 2025 | Xilio Therapeutics, Inc.Stock Option (right to buy) | Luptakova Katarina (CHIEF MEDICAL OFFICER) | Stock award | 25,000 | Not reported | Not reported | Currency not specified |
| Nov 21, 2025 | Xilio Therapeutics, Inc.Stock Option (right to buy) | Luptakova Katarina (CHIEF MEDICAL OFFICER) | Stock award | 35,000 | Not reported | Not reported | Currency not specified |
| Nov 21, 2025 | Xilio Therapeutics, Inc.Stock Option (right to buy) | Luptakova Katarina (CHIEF MEDICAL OFFICER) | Stock award | 15,000 | Not reported | Not reported | Currency not specified |
| Nov 21, 2025 | Xilio Therapeutics, Inc.Stock Option (right to buy) | Luptakova Katarina (CHIEF MEDICAL OFFICER) | Stock award | 44,210 | Not reported | Not reported | Currency not specified |
| Nov 21, 2025 | Xilio Therapeutics, Inc.Stock Option (right to buy) | Luptakova Katarina (CHIEF MEDICAL OFFICER) | Stock award | 625,000 | 0 | 0 | Currency not specified |
| Nov 21, 2025 | Xilio Therapeutics, Inc.Stock Option (right to buy) | Frankenfield Christopher James (Chief Financial Officer) | Stock award | 300,000 | Not reported | Not reported | Currency not specified |
| Nov 21, 2025 | Xilio Therapeutics, Inc.Stock Option (right to buy) | Frankenfield Christopher James (Chief Financial Officer) | Stock award | 150,000 | Not reported | Not reported | Currency not specified |
| Nov 21, 2025 | Xilio Therapeutics, Inc.Stock Option (right to buy) | Frankenfield Christopher James (Chief Financial Officer) | Stock award | 117,000 | Not reported | Not reported | Currency not specified |
| Nov 21, 2025 | Xilio Therapeutics, Inc.Stock Option (right to buy) | Frankenfield Christopher James (Chief Financial Officer) | Stock award | 20,000 | Not reported | Not reported | Currency not specified |
| Nov 21, 2025 | Xilio Therapeutics, Inc.Stock Option (right to buy) | Frankenfield Christopher James (Chief Financial Officer) | Stock award | 45,000 | Not reported | Not reported | Currency not specified |
| Nov 21, 2025 | Xilio Therapeutics, Inc.Stock Option (right to buy) | Frankenfield Christopher James (Chief Financial Officer) | Stock award | 37,296 | Not reported | Not reported | Currency not specified |
| Nov 21, 2025 | Xilio Therapeutics, Inc.Stock Option (right to buy) | Frankenfield Christopher James (Chief Financial Officer) | Stock award | 23,786 | Not reported | Not reported | Currency not specified |
Only transactions on this page are shown. Preset date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.
Transaction details
Reporting owners, quantities, prices, and source filings.
| Filed / transacted | Company | Reporting owners | Type / security | Quantity | Price / reference value | Details |
|---|---|---|---|---|---|---|
| Trade: | WILLAMETTE VALLEY VINEYARDS INCWVVI · WVVIP · company listings | TUREL STANLEY GDirector | PurchaseCommon StockNon-derivative security · Code P | 1,900 | 2.59Value: 4,921Currency not specified | View ↗ |
| Trade: | Allegion plcALLE · company listings | PETERS LAUREN BDirector | PurchaseOrdinary SharesNon-derivative security · Code P | 1,600 | 165.4409 *Value: 264,705.44Currency not specified | View ↗ |
| Trade: | Tamboran Resources CorpTBN · company listings | PACE PHILLIP ZDirector | PurchaseCommon StockNon-derivative security · Code P | 2,000 | 23.5Value: 47,000Currency not specified | View ↗ |
| Trade: | NEKTAR THERAPEUTICSNKTR · company listings | Zalevsky JonathanChief R&D Officer | Stock awardStock OptionDerivative security · Code A | 4,766 | 0Value: 0Currency not specified | View ↗ |
| Trade: | NEKTAR THERAPEUTICSNKTR · company listings | Zalevsky JonathanChief R&D Officer | Stock awardCommon StockNon-derivative security · Code A | 2,666 | 0Value: 0Currency not specified | View ↗ |
| Trade: | NEKTAR THERAPEUTICSNKTR · company listings | Wilson Mark AndrewChief Legal Officer | Stock awardStock OptionDerivative security · Code A | 3,400 | 0Value: 0Currency not specified | View ↗ |
| Trade: | NEKTAR THERAPEUTICSNKTR · company listings | Wilson Mark AndrewChief Legal Officer | Stock awardCommon StockNon-derivative security · Code A | 1,903 | 0Value: 0Currency not specified | View ↗ |
| Trade: | NEKTAR THERAPEUTICSNKTR · company listings | ROBIN HOWARD WPresident & CEO · Director | Stock awardStock OptionDerivative security · Code A | 12,170 | 0Value: 0Currency not specified | View ↗ |
| Trade: | NEKTAR THERAPEUTICSNKTR · company listings | ROBIN HOWARD WPresident & CEO · Director | Stock awardCommon StockNon-derivative security · Code A | 7,110 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Azenta, Inc.AZTA · company listings | Lin Lawrence Y.EVP, CFO and Treasurer | Stock awardCommonNon-derivative security · Code A | 36,681 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Azenta, Inc.AZTA · company listings | Pirogova OlgaSVP and CHRO | Stock awardCommonNon-derivative security · Code A | 16,303 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Azenta, Inc.AZTA · company listings | Zhou GingerSVP and GM, Multiomics | Stock awardCommonNon-derivative security · Code A | 13,042 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Azenta, Inc.AZTA · company listings | Starr EphraimSVP, Gen Counsel & Secretary | Stock awardCommonNon-derivative security · Code A | 34,235 | 0Value: 0Currency not specified | View ↗ |
| Trade: | NEWMARKET CORPNEU · company listings | GOTTWALD THOMAS EChairman, President & CEO · Director | Gift receivedCommon StockNon-derivative security · Code G | 51 | 0Value: 0Currency not specified | View ↗ |
| Trade: | NEWMARKET CORPNEU · company listings | GOTTWALD THOMAS EChairman, President & CEO · Director | Gift receivedCommon StockNon-derivative security · Code G | 51 | 0Value: 0Currency not specified | View ↗ |
| Trade: | NEWMARKET CORPNEU · company listings | GOTTWALD THOMAS EChairman, President & CEO · Director | Gift receivedCommon StockNon-derivative security · Code G | 51 | 0Value: 0Currency not specified | View ↗ |
| Trade: | NEWMARKET CORPNEU · company listings | GOTTWALD THOMAS EChairman, President & CEO · Director | Gift receivedCommon StockNon-derivative security · Code G | 51 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Ceribell, Inc.CBLL · company listings | Chao XingjuanPresident and CEO · Director | Exercise / conversionCommon StockNon-derivative security · Code M | 25,000 | 3.65Value: 91,250Currency not specified | View ↗ |
| Trade: | Ceribell, Inc.CBLL · company listings | Chao XingjuanPresident and CEO · Director | Exercise / conversionCommon StockNon-derivative security · Code M | 25,000 | 2.24Value: 56,000Currency not specified | View ↗ |
| Trade: | Reservoir Media, Inc.RSVR · company listings | Rothstein AdamDirector | Stock awardCommon stock, $0.0001 par valueNon-derivative security · Code A | 684 | 7.3Value: 4,993.2Currency not specified | View ↗ |
| Trade: | Reservoir Media, Inc.RSVR · company listings | Field Ezra S.Director | Stock awardCommon stock, $0.0001 par valueNon-derivative security · Code A | 1,712 | 7.3Value: 12,497.6Currency not specified | View ↗ |
| Trade: | Reservoir Media, Inc.RSVR · company listings | Cook Stephen M.Director | Stock awardCommon stock, $0.0001 par valueNon-derivative security · Code A | 684 | 7.3Value: 4,993.2Currency not specified | View ↗ |
| Trade: | Reservoir Media, Inc.RSVR · company listings | Taylor Ryan P.Director | Stock awardCommon stock, $0.0001 par valueNon-derivative security · Code A | 684 | 7.3Value: 4,993.2Currency not specified | View ↗ |
| Trade: | MAXIMUS, INC.MMS · company listings | Mutryn DavidChief Financial Officer | Stock awardCommon StockNon-derivative security · Code A | 10,259 | 0Value: 0Currency not specified | View ↗ |
| Trade: | MAXIMUS, INC.MMS · company listings | Martinez John ThomasChief Legal Officer | Stock awardCommon StockNon-derivative security · Code A | 7,409 | 0Value: 0Currency not specified | View ↗ |
| Trade: | MAXIMUS, INC.MMS · company listings | Baylinson Ilene R.General Mgr - Health & Human | Stock awardCommon StockNon-derivative security · Code A | 7,409 | 0Value: 0Currency not specified | View ↗ |
| Trade: | MAXIMUS, INC.MMS · company listings | Link Michelle F.Chief of Human Resources | Stock awardCommon StockNon-derivative security · Code A | 6,013 | 0Value: 0Currency not specified | View ↗ |
| Trade: | MAXIMUS, INC.MMS · company listings | GOLINVAUX THERESA DPrincipal Accounting Officer | Stock awardCommon StockNon-derivative security · Code A | 2,565 | 0Value: 0Currency not specified | View ↗ |
| Trade: | HARMONIC INC.HLIT · company listings | Jankovic WalterChief Financial Officer | Exercise / conversionCommon StockNon-derivative security · Code M | 6,645 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Strategy IncMSTR · STRC · STRD · STRF · STRK · company listings | Dietze Jane ADirector | PurchaseSeries A Perpetual Stretch Preferred StockNon-derivative security · Code P | 1,100 | 95.28Value: 104,808Currency not specified | View ↗ |
| Trade: | ClearPoint Neuro, Inc.CLPT · company listings | D'Alessandro DaniloChief Financial Officer | Exercise / conversionCommon StockNon-derivative security · Code M | 3,555 | 8.1Value: 28,795.5Currency not specified | View ↗ |
| Trade: | Enova International, Inc.ENVA · company listings | Fisher DavidChief Executive Officer · Director | Exercise / conversionCommon stock, par value $0.00001 per shareNon-derivative security · Code M | 6,000 | 23.96Value: 143,760Currency not specified | View ↗ |
| Trade: | Millrose Properties, Inc.MRP · company listings | Lynch Kathleen B.Director | PurchaseClass A Common StockNon-derivative security · Code P | 1,860 | 31.738Value: 59,032.68Currency not specified | View ↗ |
| Trade: | Xilio Therapeutics, Inc.XLO · company listings | Brennan Kevin M.SVP, FINANCE AND ACCOUNTING | Stock awardStock Option (right to buy)Derivative security · Code A | 20,000 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Xilio Therapeutics, Inc.XLO · company listings | Brennan Kevin M.SVP, FINANCE AND ACCOUNTING | Stock awardStock Option (right to buy)Derivative security · Code A | 25,000 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Xilio Therapeutics, Inc.XLO · company listings | Brennan Kevin M.SVP, FINANCE AND ACCOUNTING | Stock awardStock Option (right to buy)Derivative security · Code A | 55,000 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Xilio Therapeutics, Inc.XLO · company listings | Brennan Kevin M.SVP, FINANCE AND ACCOUNTING | Stock awardStock Option (right to buy)Derivative security · Code A | 131,700 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Xilio Therapeutics, Inc.XLO · company listings | Luptakova KatarinaCHIEF MEDICAL OFFICER | Stock awardStock Option (right to buy)Derivative security · Code A | 106,000 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Xilio Therapeutics, Inc.XLO · company listings | Luptakova KatarinaCHIEF MEDICAL OFFICER | Stock awardStock Option (right to buy)Derivative security · Code A | 25,000 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Xilio Therapeutics, Inc.XLO · company listings | Luptakova KatarinaCHIEF MEDICAL OFFICER | Stock awardStock Option (right to buy)Derivative security · Code A | 35,000 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Xilio Therapeutics, Inc.XLO · company listings | Luptakova KatarinaCHIEF MEDICAL OFFICER | Stock awardStock Option (right to buy)Derivative security · Code A | 15,000 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Xilio Therapeutics, Inc.XLO · company listings | Luptakova KatarinaCHIEF MEDICAL OFFICER | Stock awardStock Option (right to buy)Derivative security · Code A | 44,210 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Xilio Therapeutics, Inc.XLO · company listings | Luptakova KatarinaCHIEF MEDICAL OFFICER | Stock awardStock Option (right to buy)Derivative security · Code A | 625,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Xilio Therapeutics, Inc.XLO · company listings | Frankenfield Christopher JamesChief Financial Officer | Stock awardStock Option (right to buy)Derivative security · Code A | 300,000 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Xilio Therapeutics, Inc.XLO · company listings | Frankenfield Christopher JamesChief Financial Officer | Stock awardStock Option (right to buy)Derivative security · Code A | 150,000 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Xilio Therapeutics, Inc.XLO · company listings | Frankenfield Christopher JamesChief Financial Officer | Stock awardStock Option (right to buy)Derivative security · Code A | 117,000 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Xilio Therapeutics, Inc.XLO · company listings | Frankenfield Christopher JamesChief Financial Officer | Stock awardStock Option (right to buy)Derivative security · Code A | 20,000 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Xilio Therapeutics, Inc.XLO · company listings | Frankenfield Christopher JamesChief Financial Officer | Stock awardStock Option (right to buy)Derivative security · Code A | 45,000 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Xilio Therapeutics, Inc.XLO · company listings | Frankenfield Christopher JamesChief Financial Officer | Stock awardStock Option (right to buy)Derivative security · Code A | 37,296 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Xilio Therapeutics, Inc.XLO · company listings | Frankenfield Christopher JamesChief Financial Officer | Stock awardStock Option (right to buy)Derivative security · Code A | 23,786 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
50 transactions on this page. Filing date, newest first.
Filters use the date a filing was submitted, not the date of the transaction. Coverage is incomplete while historical records are being loaded. How we organize the data →